Cross ‐Country Differences in Pain Medication Before and After Spinal Cord Stimulation: A Pooled Analysis of Individual Patient Data From Two Prospective Studies in the United Kingdom and Belgium
ConclusionsOur combined analysis revealed differences in prescription practice in patients scheduled for SCS implantation between Belgium and United Kingdom. NSAIDs and neuropathic mood agents are more frequently used in the United Kingdom, presumably due to easier access to repeat prescriptions and over the counter medications. After three months of SCS, a decrease in medication use is observed in both countries, with higher reductions in Belgium, presumably due to strict regulations concerning reimbursement criteria.
Source: Neuromodulation: Technology at the Neural Interface - Category: Biotechnology Authors: Lisa Goudman,
Rui V. Duarte,
Ann De Smedt,
Sue Copley,
Sam Eldabe,
Maarten Moens Tags: Clinical Research Source Type: research
More News: Back Pain | Belgium Health | Biotechnology | Brain | Chronic Pain | Neurology | Pain | Statistics | Study | UK Health